Teva Pharmaceuticals
TEVA
TEVA
438 hedge funds and large institutions have $4.95B invested in Teva Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 64 funds opening new positions, 115 increasing their positions, 147 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
8% less funds holding in top 10
Funds holding in top 10: 12 → 11 (-1)
13% less call options, than puts
Call options by funds: $231M | Put options by funds: $265M
22% less repeat investments, than reductions
Existing positions increased: 115 | Existing positions reduced: 147
Holders
438
Holding in Top 10
11
Calls
$231M
Puts
$265M
Top Buyers
| 1 | +$227M | |
| 2 | +$80.9M | |
| 3 | +$68M | |
| 4 |
Millennium Management
New York
|
+$51M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$44.5M |
Top Sellers
| 1 | -$318M | |
| 2 | -$78.8M | |
| 3 | -$62.5M | |
| 4 |
BCP
BSN Capital Partners
London,
United Kingdom
|
-$50.7M |
| 5 |
Two Sigma Investments
New York
|
-$43.6M |